Testing the Predictability of the Relative Urinary Supersaturation from the Bonn-Risk-Index for Calcium Oxalate Stone Formation

2001 ◽  
Vol 39 (10) ◽  
Author(s):  
Norbert Laube ◽  
Stefan Hergarten ◽  
Albrecht Hesse
Keyword(s):  
Calcium Oxalate ◽  
Stone Formation ◽  
Risk Index ◽  
Calcium Oxalate Stone ◽  
Bonn Risk Index ◽  
Urinary Supersaturation

Bonn Risk Index Based Micromethod for Assessing Risk of Urinary Calcium Oxalate Stone Formation

2010 ◽  
Vol 183 (3) ◽  
pp. 1157-1162 ◽  
Author(s):  
T. Porowski ◽  
P. Mrozek ◽  
J. Sidun ◽  
W. Zoch-Zwierz ◽  
J. Konstantynowicz ◽  
...  
Keyword(s):  
Calcium Oxalate ◽  
Stone Formation ◽  
Risk Index ◽  
Urinary Calcium ◽  
Calcium Oxalate Stone ◽  
Bonn Risk Index

Are New-Generation Bisphosphonates Effective for the Inhibition of Calcium Oxalate Stone Formation in a Rat Model?

2008 ◽  
Vol 81 (3) ◽  
pp. 325-329 ◽  
Author(s):  
Erem Kaan Basok ◽  
Adnan Basaran ◽  
Necmettin Atsu ◽  
Asif Yildirim ◽  
Resit Tokuc
Keyword(s):  
Calcium Oxalate ◽  
Rat Model ◽  
Stone Formation ◽  
Calcium Oxalate Stone ◽  
New Generation

Clinical Results of Allopurinol Treatment in Prevention of Calcium Oxalate Stone Formation

1986 ◽  
Vol 136 (1 Part 1) ◽  
pp. 50-53 ◽  
Author(s):  
Hans-Göran Tiselius ◽  
Lasse Larsson ◽  
Erik Hellgren
Keyword(s):  
Calcium Oxalate ◽  
Stone Formation ◽  
Clinical Results ◽  
Calcium Oxalate Stone

The Effect of Ethane-1-Hydroxy-1,1-Diphosphonate (EHDP) on Calcium Oxalate Crystalluria in Recurrent Renal Stone-Formers

1974 ◽  
Vol 47 (1) ◽  
pp. 13-22 ◽  
Author(s):  
W. G. Robertson ◽  
M. Peacock ◽  
R. W. Marshall ◽  
F. Knowles
Keyword(s):  
Calcium Oxalate ◽  
Stone Formation ◽  
Basal Diet ◽  
Sodium Oxalate ◽  
Calcium Oxalate Crystals ◽  
Calcium Oxalate Dihydrate ◽  
Calcium Oxalate Stone ◽  
Oxalate Crystals ◽  
Stone Formers

1. The volume, size and type of calcium oxalate crystals excreted in the urine of a group of patients with recurrent ‘idiopathic’ stones were studied on a controlled basal diet, after an oral supplement of sodium oxalate and after oral administration of ethane-1-hydroxy-1,1-diphosphonate (EHDP) for 4 weeks. 2. Before administration of EHDP the stone-formers passed the large crystals and aggregates of calcium oxalate dihydrate characteristic of recurrent calcium oxalate stone-formers. For the same level of urine saturation and crystalluria EHDP caused a significant reduction in the proportion of large crystals and aggregates excreted. Studies by light-microscopy confirmed that EHDP caused a striking change in the size and habit of calcium oxalate crystals in some but not all of the urine samples examined. 3. The decrease in average crystal size during the administration of EHDP was attributed to the observed increase in the ability of urine to inhibit the growth and aggregation of calcium oxalate crystals as measured by a growth system in vitro. 4. The possible use of EHDP as a therapeutic agent in the treatment of calcium oxalate stone-formation is discussed.

Sign in / Sign up

Export Citation Format

Share Document